Older adults with long-term benzodiazepine receptor agonist use and insomnia diagnosis had significant improvements in sleep outcomes.

The decision by drug makers to stop selling such medicines follows decades of investigations and lawsuits against the drugmakers that had marketed the fast-acting painkillers.

HealthDay News — COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, according to a study published online in the October issue of ...

US health officials have warned for months about a resurgence in breakthrough infections in older children and adults, even though unvaccinated young children and newborns of unvaccinated moms remain ...

The Food and Drug Administration (FDA) has approved Sarclisa ® (isatuximab-irfc) in combination with bortezomib, lenalidomide and dexamethasone (VRd) for the treatment of patients with newly diagnosed ...

No increased risk noted for prespecified outcomes, including preeclampsia or eclampsia, placental abruption, preterm birth, SGA ...

Three of the four states had corresponding evidence of human influenza activity from other surveillance systems ...

HealthDay News — After SARS-CoV-2 infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute sequalae of SARS-CoV-2 (PASC), according to a study published ...

HealthDay News — Americans have the worst health care among the world’s wealthy nations, a new report says. People in the US die the earliest and live the sickest lives out of 10 developed countries, ...

FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.

The Food and Drug Administration (FDA) has approved Miplyffa ™ (arimoclomol) for use in combination with miglustat for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) ...

Findings showed treatment with Rybrevant plus chemotherapy significantly reduced the risk of disease progression or death by 52% compared with chemotherapy.